OTCMKTS:MCVEF Medicover AB (publ) (MCVEF) Stock Price, News & Analysis $27.25 0.00 (0.00%) As of 10/27/2026 Add Compare Share Share Stock Analysis Stock AnalysisChart About Medicover AB (publ) Stock (OTCMKTS:MCVEF) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Medicover AB (publ) alerts:Sign Up Key Stats Today's Range$27.25▼$27.2550-Day Range$27.25▼$27.2552-Week Range$27.00▼$27.25VolumeN/AAverage Volume925 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Medicover AB (publ) is a Swedish healthcare and diagnostics company that provides medical services to individuals, employers, insurers and other institutional customers. Its operations are organized primarily into Healthcare Services and Diagnostic Services. The Healthcare Services business offers outpatient care through hospitals, clinics and medical centers, including primary care, specialist consultations, occupational health, dental care and related services. The Diagnostic Services business provides laboratory testing, pathology, imaging and other diagnostic services for patients, physicians, hospitals and corporate customers. Founded in 1995, Medicover serves customers mainly in Europe and India, with significant operations in countries including Poland, Germany, Romania, Ukraine and India. The company has expanded through the development and acquisition of healthcare facilities, laboratories and supporting medical-service businesses. Medicover AB is headquartered in Stockholm, Sweden, and its shares are listed on Nasdaq Stockholm. The company is led by a professional executive management team and overseen by a board of directors; leadership details may change over time.AI Generated. May Contain Errors. Read More Receive MCVEF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Medicover AB (publ) and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. MCVEF Stock News HeadlinesMedicover : nomination committee for the AGM 2027September 24, 2026 | marketscreener.comMMedicover AB (publ) (MCVEY) Q1 2026 Earnings Call TranscriptApril 29, 2026 | seekingalpha.comThe chip inside every TeslaEvery Tesla built since 2012 pays this small, overlooked supplier a fee for its technology. So does every Starlink dish and AI satellite Elon launches. When Nvidia tried to buy the company, Elon reportedly fought the deal. Now his filing for 1,000,000 satellites could expand its revenue stream sharply. Dylan believes the stock could see significant movement starting December 8th.October 28 at 1:00 AM | Behind the Markets (Ad)European Growth Stocks With High Insider Ownership For September 2025September 2, 2025 | finance.yahoo.comInsider Favorites: 3 Growth Companies With Strong OwnershipJanuary 15, 2025 | finance.yahoo.com3 Growth Companies With High Insider Ownership Expecting Up To 86% Earnings GrowthDecember 12, 2024 | sg.finance.yahoo.comMedicover to evaluate a potential separate listing in IndiaDecember 11, 2024 | finance.yahoo.comMCVEF Medicover AB (publ)November 28, 2024 | seekingalpha.comSee More Headlines MCVEF Stock Analysis - Frequently Asked Questions How have MCVEF shares performed this year? Medicover AB (publ)'s stock was trading at $27.25 on January 1st, 2026. Since then, MCVEF shares have increased by 0.0% and is now trading at $27.25. How do I buy shares of Medicover AB (publ)? Shares of MCVEF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Today10/28/2026Next Earnings (Estimated)11/04/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorHealthcare Industry Healthcare Providers & Services Sub-IndustryN/A Current SymbolOTCMKTS:MCVEF CIKN/A Webwww.medicover.com Phone46.8.400.17.600FaxN/AEmployees45,000Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A The 7 Best High-Yield Dividend Stocks for 2027Looking for higher dividend income in 2027? Discover seven high-yield dividend stocks with attractive payouts, proven dividend histories and growth potential.Get This Free Report This page (OTCMKTS:MCVEF) was last updated on 10/27/2026 by MarketBeat.com Staff. From Our PartnersFinancial legend: “This is bad, really bad...”Dr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each war...Weiss Ratings | SponsoredElon Musk’s One Stock Retirement PlanJeff Brown picked Nvidia in 2016, before it surged 37,000 percent. Now he's tracking a small AI company he say...Brownstone Research | SponsoredExecutive Order 14241 Unleashes Trump’s New DollarA landmark executive order, 14241, is reportedly set to reshape how Americans use money starting this December...Porter & Company | SponsoredDon't lose access to thisIan Cooper is giving away his guide, The Simple Path To Success With Options, before it moves behind a paywall...TradeWins | SponsoredNvidia's $550 Trillion ProblemDo not buy another AI stock until you've seen the arithmetic below. Nvidia is worth about $5.5 trillion. Al...Decentralized Masters | SponsoredLast call for your free 0DTE reportThe 0DTE Game Plan lays out a simple 3-step framework for trading same-day options: Plan it, profit from it, p...Profits Run | SponsoredMy Deep Cut Pick Before Anthropic's IPOThe biggest IPO in history is likely just weeks away... at a valuation of up to $2 trillion Anthropic could ma...Crypto 101 Media | SponsoredTwo charts tell you the future…Gold miners are posting record cash flows, outperforming every other sector, yet mining still makes up just 1%...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Medicover AB (publ) Please log in to your account or sign up in order to add this asset to your watchlist. Share Medicover AB (publ) With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
